Statement Of Income And Retained Earnings

OncoTherapy Science, Inc. - Filing #7253509

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-577,960,000 JPY
-90,519,000 JPY
-728,484,000 JPY
-487,441,000 JPY
-797,936,000 JPY
-219,976,000 JPY
-235,633,000 JPY
-910,192,000 JPY
-210,607,000 JPY
-1,120,800,000 JPY
-674,559,000 JPY
-889,202,000 JPY
Non-operating income
Non-operating income
34,604,000 JPY
2,242,000 JPY
26,000 JPY
30,742,000 JPY
Non-operating expenses
Non-operating expenses
18,150,000 JPY
19,352,000 JPY
15,599,000 JPY
14,896,000 JPY
Ordinary profit (loss)
-712,030,000 JPY
-815,046,000 JPY
-1,136,373,000 JPY
-873,356,000 JPY
Extraordinary income
Extraordinary income
34,867,000 JPY
2,200,000 JPY
5,225,000 JPY
269,528,000 JPY
Extraordinary losses
Extraordinary losses
136,830,000 JPY
279,000 JPY
154,564,000 JPY
402,744,000 JPY
Profit (loss) before income taxes
-813,992,000 JPY
-813,125,000 JPY
-1,285,713,000 JPY
-1,006,572,000 JPY
Income taxes - current
1,210,000 JPY
2,160,000 JPY
2,425,000 JPY
1,210,000 JPY
Profit (loss)
-815,202,000 JPY
-815,202,000 JPY
-815,202,000 JPY
-815,202,000 JPY
-815,285,000 JPY
-1,007,782,000 JPY
-1,288,138,000 JPY
-1,007,782,000 JPY
-1,007,782,000 JPY
-1,007,782,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.